Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Raymed Ophthalmic Private Limited, is an unlisted private company incorporated on 02 May, 2019. It is classified as a private limited company and is located in , Chandigarh. It's authorized share capital is INR 2.00 cr and the total paid-up capital is INR 1.00 cr.
The current status of Raymed Ophthalmic Private Limited is - Active.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Sanjay Jhamb | 07633799 | 7 years |
| Additional Director | Sanjiv Kumar Kansal | 08521073 | 5 years |
| Director | Ashish Sachdeva | 08068960 | 7 years |
| Director | Tarsem Kumar Ruby | 00957764 | 7 years |
| Director | Shivansh Sharma | 07159961 | 7 years |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| RAYCURE DRUGS LIMITED |
Active
|
5.0 L | 2 | Chandigarh |
| AYURAY ORGANICS PRIVATE LIMITED |
Active
|
25.0 L | 2 | Chandigarh |
| RAYMAZON PHARMALINKS PRIVATE LIMITED |
Active
|
1.0 L | 1 | Chandigarh |
| RAYMZON TRADE LINKS PRIVATE LIMITED |
Active
|
1.0 L | 2 | Chandigarh |
| AQUAVISION PHARMACEUTICALS PRIVATE LIMITED |
Active
|
25.0 L | 2 | Chandigarh |
| OJAS MEDICAL SERVICES PRIVATE LIMITED |
Active
|
15.5 Cr | 1 | Haryana |
| RAYMED PHARMACEUTICALS LIMITED |
Active
|
17.1 L | 2 | Chandigarh |
| INDIA HEALTH SERVICES PRIVATE LIMITED |
Active
|
1.0 L | 1 | Chandigarh |
Read more
The incorporation date of RAYMED OPHTHALMIC PRIVATE LIMITED is 02 May, 2019
The authorized share capital of RAYMED OPHTHALMIC PRIVATE LIMITED is INR ₹ 2.0 Cr.
The paid-up capital of RAYMED OPHTHALMIC PRIVATE LIMITED is INR ₹ 1.0 Cr.
The registered address of RAYMED OPHTHALMIC PRIVATE LIMITED is SCO-859 NAC MANIMAJRA, Chandigarh, CHANDIGARH, Chandigarh, India, 160101 - 160101
The CIN number of RAYMED OPHTHALMIC PRIVATE LIMITED is U24290CH2019PTC042483.